I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists.
Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
RAD1901, a novel tissue-selective estrogen receptor degrader (SERD) demonstrates estrogen receptor engagement in a phase 1 clinical study
Published in: Cancer Research
Gary Hattersley, Frank David, Alan W. Harris, Marcie Clarkin, Kate Banks, Greg Williams,
Andor Glaudemans,
Janine Doorduin, Michel J. B. Koole,
Erik de Vries, Rich Lyttle
Breast cancer: a new imaging approach as an addition to existing guidelines
Published in: European Journal of Nuclear Medicine and Molecular Imaging
IMPACT: op weg naar een gepersonaliseerde antikankerbehandeling met behulp van moleculaire beeldvorming. Drie lopende studies voor mamma-, colorectaal en niercelcarcinoom
E J van Helden, Suzanne van Es,
Frederike Bensch, E Boon, C W Menke-van der Houven van Oordt,
Carolina Schröder, C M L van Herpen,
Adrienne Brouwers,
Andor W.J.M. Glaudemans, O S Hoekstra, W.J.G. Oyen, W.T.A. van der Graaf, H M V Verheul,
E. G. E. de Vries
Molecular imaging of infectious and inflammatory diseases: A terra incognita
Published in: Journal of Nuclear Medicine
PET beyond F-18-FDG: second generation PET tracers in clinical oncology
